Navigation Links
Regulus Reports Third Quarter 2013 Financial Results and Recent Highlights
Date:11/13/2013

diseases and oncology.

Third Quarter 2013 Highlights

  • Advanced Additional Therapeutic Programs; Proprietary Efforts Focused on Oncology and Orphan Diseases. Regulus continued to pursue several additional programs, both independently and with its strategic alliance partners, targeting miR-21 for oncology indications, targeting miR-221 for the treatment of HCC, targeting miR-10b for the treatment of glioblastoma, and targeting miR-33 for atherosclerosis. Additionally, Regulus continues to advance its proprietary efforts with the identification of several attractive microRNA targets, namely for oncology indications and orphan diseases.
  • Completed Successful Public Offering of Common Stock. Regulus completed an underwritten public offering of 5,175,000 shares of common stock resulting in $45.8 million of aggregate net proceeds, after deducting underwriting discounts and commissions and estimated offering expenses payable by Regulus. Primarily as a result of the successful offering, Regulus revised its prior year-end cash guidance of ending 2013 with at least $60 million in cash, cash equivalents and short-term investments to ending 2013 with approximately $110 million in cash, cash equivalents and short-term investments.
  • Third Quarter 2013 Financial Results & HighlightsAs of September 30, 2013, Regulus had $123.9 million in cash, cash equivalents and short-term investments, including $45.8 million in net proceeds from a public offering of 5,175,000 shares of common stock issued at an offering price of $9.50 per share, which was completed in July 2013.  

    Regulus reported a net loss of $2.2 million for the three months ended September 30, 2013, compared to a net loss of $5.7 million for the same period in 2012.  Basic and diluted net loss per share was $0.05 and $0.07 for the three months ended September 30, 2013, respectively, compared to basic and di
    '/>"/>

    SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. Regulus Presents Positive Preclinical Data Demonstrating that microRNA-21 Plays an Important Role in Alport Syndrome
    2. Regulus Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
    3. Regulus Announces Significant Progress in Strategic Alliance with AstraZeneca and Selection of a New Pre-Clinically Validated microRNA Oncology Target
    4. Regulus Reports Second Quarter 2013 Financial Results and Recent Highlights
    5. Regulus Announces Timing for Second Quarter 2013 Financial Results Webcast and Conference Call
    6. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
    7. Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference
    8. Regulus Provides Update on Road to the Clinic Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
    9. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
    10. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
    11. Regulus to Present at Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... YORK , April 20, 2015 This ... and Leasing in US$ Million. The report provides separate ... , Europe , and Rest of ... period 2014 through 2020. Also, a seven-year historic analysis ... are derived from primary and secondary research. Company profiles ...
    (Date:4/20/2015)... YORK , April 20, 2015 This report ... Instruments in US$ Million by the following Product Segments: Sphygmomanometers ... and Blood Pressure Transducers. The report provides separate comprehensive analytics ... Japan , Europe , ... Latin America . Annual estimates and forecasts ...
    (Date:4/20/2015)... 2015  SillaJen, Inc., a private clinical-stage biotherapeutics ... products for cancer, today announced an oral and ... of the American Association for Cancer Research (AACR) ... of its lead product candidate, Pexa-Vec (JX-594) with ... immunotherapy designed to 1) rapidly de-bulk tumors via ...
    Breaking Medicine Technology:World Medical Equipment Rental and Leasing Industry 2World Medical Equipment Rental and Leasing Industry 3World Medical Equipment Rental and Leasing Industry 4World Medical Equipment Rental and Leasing Industry 5World Medical Equipment Rental and Leasing Industry 6World Medical Equipment Rental and Leasing Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 2World Blood Pressure Monitoring and Measurement Instruments Industry 3World Blood Pressure Monitoring and Measurement Instruments Industry 4World Blood Pressure Monitoring and Measurement Instruments Industry 5World Blood Pressure Monitoring and Measurement Instruments Industry 6World Blood Pressure Monitoring and Measurement Instruments Industry 7World Blood Pressure Monitoring and Measurement Instruments Industry 8World Blood Pressure Monitoring and Measurement Instruments Industry 9World Blood Pressure Monitoring and Measurement Instruments Industry 10World Blood Pressure Monitoring and Measurement Instruments Industry 11World Blood Pressure Monitoring and Measurement Instruments Industry 12World Blood Pressure Monitoring and Measurement Instruments Industry 13World Blood Pressure Monitoring and Measurement Instruments Industry 14World Blood Pressure Monitoring and Measurement Instruments Industry 15World Blood Pressure Monitoring and Measurement Instruments Industry 16World Blood Pressure Monitoring and Measurement Instruments Industry 17World Blood Pressure Monitoring and Measurement Instruments Industry 18World Blood Pressure Monitoring and Measurement Instruments Industry 19World Blood Pressure Monitoring and Measurement Instruments Industry 20World Blood Pressure Monitoring and Measurement Instruments Industry 21World Blood Pressure Monitoring and Measurement Instruments Industry 22World Blood Pressure Monitoring and Measurement Instruments Industry 23World Blood Pressure Monitoring and Measurement Instruments Industry 24World Blood Pressure Monitoring and Measurement Instruments Industry 25World Blood Pressure Monitoring and Measurement Instruments Industry 26World Blood Pressure Monitoring and Measurement Instruments Industry 27World Blood Pressure Monitoring and Measurement Instruments Industry 28SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 2SillaJen Presents Data Demonstrating Pexa-Vec Synergy with Angiogenesis Inhibitors: A Collaboration with University of California, San Francisco 3
    ... - Neose Technologies,Inc. (Nasdaq GM:NTEC) today ... with its collaborative partner, Novo Nordisk ... at the XXIst,Congress of the International ... Switzerland. The data presented demonstrates that,GlycoPEGylation(TM) ...
    ... On Wednesday,July 11, 2007, at 1:30 p.m. ... of Cell Therapeutics, Inc.'s (CTI),management team will ... of the interim results of its phase ... which pixantrone is substituted for,doxorubicin in standard ...
    Cached Medicine Technology:Neose Announces Presentation of Positive Preclinical Data on,GlycoPEGylated Factor VIIa at the XXI Congress of the International,Society on Thrombosis and Haemostasis 2Cell Therapeutics, Inc. Management to Discuss Today's Announcement,of Interim Pixantrone Study Results 2
    (Date:4/21/2015)... (PRWEB) April 21, 2015 In early ... in blue lights to draw attention to a growing ... during this time is the unique educational needs of ... spectrum is wide and diverse and each autistic person ... remains constant. That is, the educational and emotional needs ...
    (Date:4/21/2015)... April 21, 2015 On May ... grand opening of its Center for Graduate Studies, ... Presbyterian Hospital. The campus recently completed a stunning ... only thing that has administrators and students abuzz. ... from the Master of Science in Nursing, Post-Master’s ...
    (Date:4/21/2015)... The Science Museum of Virginia welcomes theoretical ... its Lunch Break Science program. On Wednesday, April 29, Dr. ... guests from the subatomic world of quantum mechanics to astronomical ... members of the community to grab lunch and take a ... will delve into the nucleus and dissect the complex world ...
    (Date:4/21/2015)... Freeslate, Inc ., the leading provider ... that the Centre for Catalysis Research and Innovation ... a Freeslate Core Module 3 (CM3) Reaction Screening ... to accelerate current research programs. The systems will be ... be available to academic users and industrial collaborators/ partners ...
    (Date:4/21/2015)... 2015 Invictus Medical has secured ... university for a second innovative technology aimed at ... to newborn infants’ cognitive development. , “This technology ... we have identified through extensive interviews and input ... Hutchinson, Invictus Medical’s Chief Technology Officer. “We believe ...
    Breaking Medicine News(10 mins):Health News:In Light of Autism Awareness Month,The Glenholme School Illuminates the Benefits of Therapeutic Boarding School for Students on the Spectrum 2Health News:In Light of Autism Awareness Month,The Glenholme School Illuminates the Benefits of Therapeutic Boarding School for Students on the Spectrum 3Health News:In Light of Autism Awareness Month,The Glenholme School Illuminates the Benefits of Therapeutic Boarding School for Students on the Spectrum 4Health News:West Coast University Opens a Center for Graduate Studies 2Health News:West Coast University Opens a Center for Graduate Studies 3Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:Invictus Medical Secures Rights to Second Promising New NICU Technology 2
    ... health risks, experts note, , WEDNESDAY, June 10 ... Administration advisory panel is expected to vote Wednesday ... be approved for use by children. , The ... as Geodon, Seroquel, and Zyprexa, currently approved for ...
    ... Medical Services Will Host Free Health and Dental Screenings June ... , PITTSBURGH, June 10 As Pennsylvania and ... many individuals have subsequently faced job loss or the loss ... will help those in need by hosting a day of ...
    ... Application Deadline: August 14, 2009 , , ITASCA, ... drug retailer, announced today that the company will begin accepting ... the operational needs of food pantries and soup kitchens. , ... grant program is conducted in partnership with three "Feeding America" ...
    ... Kensey Nash Corporation (Nasdaq: KNSY ) is ... on Thursday, June 18, 2009. , , Joseph ... Company,s presentation, beginning at approximately 9:00 a.m. (ET). To ... to http://www.wsw.com/webcast/jeff35/knsy/ . The presentation materials will also ...
    ... Anthropedia Foundation, a non-profit organization with headquarters in the United ... will host its first annual gala. The black tie event ... Manoir, a five-star Relais & Chateaux Hotel on Lake Murten ... scientists, and distinguished guests will enjoy a special evening in ...
    ... So many classic childhood movies (Dumbo) and sing-a-longs (Do your ... large and protruding ears. But it turns out that ... teenager. According to the American Academy of ... reshaping of the ear by placing small incisions behind the ...
    Cached Medicine News:Health News:FDA Panel Mulls Newer Antipsychotics for Kids 2Health News:FDA Panel Mulls Newer Antipsychotics for Kids 3Health News:FDA Panel Mulls Newer Antipsychotics for Kids 4Health News:Highmark to Sponsor Partners for a Healthy Community Event in Uniontown 2Health News:Highmark to Sponsor Partners for a Healthy Community Event in Uniontown 3Health News:JEWEL-OSCO(R) Hunger Relief Grant Program Helping to Fund Area Food Pantries & Soup Kitchens 2Health News:JEWEL-OSCO(R) Hunger Relief Grant Program Helping to Fund Area Food Pantries & Soup Kitchens 3Health News:Anthropedia Foundation Charity Gala, Murten, Switzerland, in the Presence of HSH Prince Albert II of Monaco 2
    Reliavac 100cc evacuators offer a more constant suction profile than silicone evacuators. 100cc capacity is easy for patient to carry. Bottom emptying port reduces chance of contamination....
    100cc silicone evacuator...
    Single round silicone drain with 10 in. hole pattern, 49 in. long...
    Siliconized PVC drains...
    Medicine Products: